"10.1371_journal.pone.0107743","plos one","2014-09-16T00:00:00Z","Mandy Sowa; Kai Grossmann; Ilka Knütter; Rico Hiemann; Nadja Röber; Ursula Anderer; Elena Csernok; Dimitrios P Bogdanos; Maria Orietta Borghi; Pier Luigi Meroni; Peter Schierack; Dirk Reinhold; Karsten Conrad; Dirk Roggenbuck","Research and Development Department, GA Generic Assays GmbH, Dahlewitz/Berlin, Germany; Faculty of Science, Brandenburg University of Technology Cottbus-Senftenberg, Senftenberg, Germany; Institute of Immunology, Technical University of Dresden, Dresden, Germany; Department of Rheumatology, University of Schleswig-Holstein Campus Lübeck and Rheumaklinik Bad Bramstedt, Bad Bramstedt, Germany; Division of Transplantation, Immunology and Mucosal Biology, King's University College, London, United Kingdom; Department of Rheumatology, University of Milan, Milan, Italy; Institute of Molecular and Clinical Immunology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany","Performed the experiments: MS IK KG NR RH. Analyzed the data: KC D. Reinhold UA EC PS D. Roggenbuck. Contributed reagents/materials/analysis tools: KC PLM MOB DPB EC. Contributed to the writing of the manuscript: MS D. Roggenbuck. Developed the CytoBead ANCA assay: MS KG. Carried out indirect immunofluorescence assays: MS KG NR. Developed the pattern recognition algorithms: RH.","Dirk Roggenbuck has a management role and is a shareholder of GA Generic Assays GmbH and Medipan GmbH. Both companies are diagnostic manufacturers. All other authors declare that they have no competing financial interests. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2014","09","Mandy Sowa","MS",14,TRUE,NA,5,2,NA,TRUE,FALSE,TRUE,2,"6;11",TRUE
